May 21, 2018 Last Updated 3:09 PM, May 17, 2018

Decision by Europe’s top court alarms vaccine experts

Published in News
Read 815 times
Rate this item
(0 votes)

A recent ruling by the European Court of Justice has alarmed clinicians and scientists all over the world due to the controversial decision of not considering solid "scientifical proof" as the only element in evaluating a possible connection between vaccines (or other clinical treatments) and diseases.

Apparently, plaintiffs could be allowed to use other evidences, including circumstantial ones, while pleading their case, even in the presence of inconclusive scientific studies. Nonetheless, the "burden of proof" remains, of course, on the plaintiff, which is still required to have preponderance of evidences in order to prove a correlation between the treatment and the clinical condition, while the manufacturers can easily use solid epidemiological study showing no convincing evidence of a connection.

Gretchen Vogel discusses the caveats of this delicate matter on Science News.

  Link to the original paper

Last modified on Tuesday, 09 January 2018 14:54
Login to post comments

Registered area

Thanks to the support of
merck serono biogen sanofi

Conferences & Courses

17° Corso CRNI Viva la differenza: sesso e neuroimmunologia

March 7-10, 2018 
Bergamo - Bergamo Science Center

READ MORE

Encefaliti Autoimmuni e Malattie Demielinizzanti Atipiche

16 febbraio 2018
Aula Magna Giorgio De Sandre
POLICLINICO UNIVERSITARIO G.B. ROSSI - Verona

READ MORE

JNIInternational Brain Research Organization
Bringing Neuroscience to the World
JNIJournal of Neuroimmunology
Studies on all branches of neurosciences covering both research and clinical problems of neuroscientific interest.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie Policy